ara-CDP-1-S-octadecyl-2-O-palmitoyl-1-thioglycerol: RN refers to di-Na salt; RN & structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6336766 |
| MeSH ID | M0175944 |
| Synonym |
|---|
| cytoros |
| 125592-28-1 |
| 2(1h)-pyrimidinone, 4-amino-1-(5-o-(1,3-dihydroxy-6-((1-oxohexadecyl)oxy)-2,4-dioxa-8-thia-1,3-diphosphahexacos-1-yl)-beta-d-arabinofuranosyl)-, p,p'-dioxide, disodium salt |
| ara-cdp-ptba |
| ara-cdp-1-s-octadecyl-2-o-palmitoyl-1-thioglycerol |
| 1-beta-arabinofuranosylcytosine 5'-diphosphate-1-octadecyl-2-o-palmitoyl-1-thioglycerol |
| a-cdp-optg |
| disodium;[1-[[[(2r,3s,4s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3-octadecylsulfanylpropan-2-yl] hexadecanoate |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (20.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||